Titel

Merkliste
1 Ergebnisse

Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients Wit..:

Carvelli, Julien ; Meziani, Ferhat ; Dellamonica, Jean...
info:eu-repo/semantics/altIdentifier/doi/10.1097/ccm.0000000000005683. , 2022

Link: https://amu.hal.science/hal-03952765

RT Journal
T1 <Title>Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-03952765v1&Exemplar=1&LAN=DE
				
A1 Carvelli, Julien
A1 Meziani, Ferhat
A1 Dellamonica, Jean
A1 Cordier, Pierre-Yves
A1 Allardet-Servent, Jerome
A1 Fraisse, Megan
A1 Velly, Lionel
A1 Barbar, Saber, Davide
A1 Lehingue, Samuel
A1 Guervilly, Christophe
A1 Desgrouas, Maxime
A1 Camou, Fabrice
A1 Piperoglou, Christelle
A1 Vely, Frederic
A1 Demaria, Olivier
A1 Karakunnel, Joyson
A1 Fares, Joanna
A1 Batista, Luciana
A1 Rotolo, Federico
A1 Viotti, Julien
A1 Boyer-Chammard, Agnes
A1 Lacombe, Karine
A1 Le Dault, Erwan
A1 Carles, Michel
A1 Schleinitz, Nicolas
A1 Vivier, Eric
PB HAL CCSD; Lippincott, Williams & Wilkins
YR 2022
K1 avdoralimab
K1 complement
K1 COVID-19
K1 inflammation
K1 sepsis
K1 [SDV]Life Sciences [q-bio]
JF info:eu-repo/semantics/altIdentifier/doi/10.1097/ccm.0000000000005683
LK http://dx.doi.org/https://amu.hal.science/hal-03952765
DO https://amu.hal.science/hal-03952765
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)